Beyond Air Publishes New Data on Nitric Oxide to Treat M. Abscessus in the Peer-Reviewed Journal Access Microbiology
August 10, 2020
Beyond Air® Reports Financial Results for First Quarter of Fiscal Year 2021 and Provides Business Update
August 6, 2020
Beyond Air® to Announce Fiscal First Quarter 2021 Financial Results on Thursday, August 6th
July 23, 2020
Beyond Air Reports Financial Results for Fiscal Fourth Quarter and Year-End 2020
June 22, 2020
Beyond Air Announces Positive Preclinical Data Supporting High Concentration Nitric Oxide as a Potential Treatment for Solid Tumors
June 22, 2020
Beyond Air Announces First Patient Enrolled in its U.S. Study of Nitric Oxide Therapy Using the LungFit™ System in COVID-19 Patients
June 15, 2020
Beyond Air Announces Publication of Peer-Reviewed Journal Article in Scientific Reports
June 15, 2020
Beyond Air™ Scheduled to Announce Fiscal Year 2020 Financial Results on Monday, June 22nd
June 8, 2020
Beyond Air Receives Approval from Health Canada to Study Nitric Oxide Generated and Delivered by the LungFit™ in COVID-19 Patients
May 26, 2020
Beyond Air Achieves Primary Endpoint in Pilot Bronchiolitis Study
May 20, 2020

Sign up for updates from Beyond Air, Inc.

Unsubscribe from all email communications. Unsubscribe